Patents by Inventor Stephen Clement PISCITELLI

Stephen Clement PISCITELLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING A NEURODEGENERATIVE DISEASE
    Publication number: 20190111052
    Abstract: The present application relates to new uses of 5-HT6 receptor antagonists, specifically high doses of 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, and to the combination of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, with, an acetylcholinesterase inhibitor for the treatment of a neurodegenerative disease.
    Type: Application
    Filed: July 19, 2018
    Publication date: April 18, 2019
    Inventors: Lawrence Tim FRIEDHOFF, Stephen Clement PISCITELLI, Kunal KISHNANI, Shankar RAMASWAMY, Bryan M. LEWIS
  • COMPOSITIONS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE
    Publication number: 20180042922
    Abstract: The present application relates to novel compositions useful for the treatment of a neurodegenerative disease and uses thereof. The present application also relates to novel compositions and methods for the reduction of side effects in a subject being treated for a neurodegenerative disease. The present application also relates to novel compositions and methods for enhancing the standard of care of the treatment of a neurodegenerative disease. The present application also relates to novel compositions and methods for enhancing the efficacy of one or more treatments for a neurodegenerative disease.
    Type: Application
    Filed: August 15, 2017
    Publication date: February 15, 2018
    Inventors: Pavan Kumar CHERUVU, Kunal KISHNANI, Bryan M. LEWIS, Stephen Clement PISCITELLI, Shankar RAMASWAMY, Gregory M. WEINHOFF, Ebenezer ASARE
  • COMPOSITIONS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE
    Publication number: 20160324852
    Abstract: The present application relates to new uses of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or pharmaceutically acceptable salts, hydrates, solvates, or polymorphs, thereof, and to the combination of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or pharmaceutically acceptable salts, hydrates, solvates, or polymorphs, thereof, with other therapeutic agents for the treatment of a neurodegenerative disease.
    Type: Application
    Filed: May 6, 2016
    Publication date: November 10, 2016
    Inventors: Lawrence Tim FRIEDHOFF, Melissa RHODES, Stephen Clement PISCITELLI, Kunal KISHNANI, Shankar RAMASWAMY, Bryan M. LEWIS, Geetha RAMASWAMY
  • METHODS OF TREATING A NEURODEGENERATIVE DISEASE
    Publication number: 20160324851
    Abstract: The present application relates to new uses of 5-HT6 receptor antagonists, specifically high doses of 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, and to the combination of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline, with, an acetylcholinesterase inhibitor for the treatment of a neurodegenerative disease.
    Type: Application
    Filed: May 6, 2016
    Publication date: November 10, 2016
    Inventors: Lawrence Tim FRIEDHOFF, Stephen Clement PISCITELLI, Kunal KISHNANI, Shankar RAMASWAMY, Bryan M. LEWIS